Patten & Patten Inc. TN Lowers Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Patten & Patten Inc. TN lessened its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) by 6.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 6,710 shares of the exchange traded fund’s stock after selling 495 shares during the quarter. Patten & Patten Inc. TN’s holdings in SPDR S&P Biotech ETF were worth $599,000 as of its most recent SEC filing.

Several other hedge funds also recently bought and sold shares of the stock. Roundview Capital LLC boosted its stake in shares of SPDR S&P Biotech ETF by 275.4% in the first quarter. Roundview Capital LLC now owns 7,599 shares of the exchange traded fund’s stock valued at $683,000 after purchasing an additional 5,575 shares during the period. U.S. Capital Wealth Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF in the first quarter valued at approximately $222,000. Synovus Financial Corp boosted its stake in shares of SPDR S&P Biotech ETF by 559.1% in the first quarter. Synovus Financial Corp now owns 15,462 shares of the exchange traded fund’s stock valued at $1,390,000 after purchasing an additional 13,116 shares during the period. Vontobel Holding Ltd. boosted its stake in shares of SPDR S&P Biotech ETF by 6.7% in the first quarter. Vontobel Holding Ltd. now owns 6,400 shares of the exchange traded fund’s stock valued at $575,000 after purchasing an additional 400 shares during the period. Finally, Sequoia Financial Advisors LLC boosted its stake in shares of SPDR S&P Biotech ETF by 17.6% in the first quarter. Sequoia Financial Advisors LLC now owns 2,234 shares of the exchange traded fund’s stock valued at $201,000 after purchasing an additional 334 shares during the period.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA XBI opened at $90.68 on Wednesday. SPDR S&P Biotech ETF has a one year low of $63.80 and a one year high of $103.52. The firm has a 50 day simple moving average of $93.71 and a 200-day simple moving average of $83.03. The firm has a market cap of $6.96 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97.

About SPDR S&P Biotech ETF

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

See Also

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.